Palisade Asset Management’s Edwards Lifesciences EW Stock Holding History

Palisade Asset Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$390K	Sell	4,315 -2	-0%	-$168	0.04%	172
2026 Q1	$346K	Hold	4,317	–	–	0.03%	167
2025 Q4	$368K	Sell	4,317 -20	-0.5%	-$1.64K	0.04%	160
2025 Q3	$337K	Buy	4,337 +2	+0%	+$156	0.03%	171
2025 Q2	$339K	Sell	4,335 -650	-13%	-$48.5K	0.03%	168
2025 Q1	$361K	Hold	4,985	–	–	0.04%	162
2024 Q4	$369K	Hold	4,985	–	–	0.04%	162
2024 Q3	$329K	Hold	4,985	–	–	0.03%	168
2024 Q2	$460K	Hold	4,985	–	–	0.05%	158
2024 Q1	$476K	Hold	4,985	–	–	0.05%	158
2023 Q4	$380K	Sell	4,985 -1,245	-20%	-$86.6K	0.04%	159
2023 Q3	$432K	Hold	6,230	–	–	0.05%	147
2023 Q2	$588K	Hold	6,230	–	–	0.07%	136
2023 Q1	$515K	Hold	6,230	–	–	0.06%	139
2022 Q4	$465K	Hold	6,230	–	–	0.05%	150
2022 Q3	$515K	Hold	6,230	–	–	0.07%	135
2022 Q2	$592K	Hold	6,230	–	–	0.08%	132
2022 Q1	$733K	Hold	6,230	–	–	0.08%	127
2021 Q4	$807K	Hold	6,230	–	–	0.09%	121
2021 Q3	$705K	Hold	6,230	–	–	0.09%	123
2021 Q2	$645K	Hold	6,230	–	–	0.08%	127
2021 Q1	$521K	Buy	6,230 +20	+0.3%	+$1.69K	0.07%	138
2020 Q4	$567K	Buy	6,210 +120	+2%	+$9.95K	0.08%	131
2020 Q3	$486K	Hold	6,090	–	–	0.07%	131
2020 Q2	$421K	Hold	6,090	–	–	0.07%	134
2020 Q1	$383K	Hold	6,090	–	–	0.07%	139
2019 Q4	$474K	Buy	+6,090	New	+$476K	0.07%	134

Other funds holding EW

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Palisade Asset Management's EW Position: Q2 2026 in Review

Palisade Asset Management reduced its Edwards Lifesciences (EW) stake by 0.05% in Q2 2026, selling an estimated $168 and leaving 4,315 shares worth $390K. The position accounts for 0.04% of the portfolio, ranked #172.

Palisade Asset Management first reported a position in EW in Q4 2019 and has held it in 27 quarters since. The position peaked at $807K in Q4 2021. 327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Palisade Asset Management held 4,315 shares of Edwards Lifesciences worth $390K as of Q2 2026.
Palisade Asset Management sold 2 Edwards Lifesciences shares in Q2 2026, an estimated $168.
Edwards Lifesciences made up 0.04% of Palisade Asset Management's portfolio in Q2 2026, its #172 holding.
Palisade Asset Management first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 27 quarters since.
Palisade Asset Management's Edwards Lifesciences position peaked at $807K in Q4 2021.
327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Palisade Asset Management's 13F filing for Q2 2026, filed 20 Jul 2026.